U.K. releases Eprex letter

The U.K. Medicines Control Agency posted a safety message regarding 40 cases of pure red cell aplasia (PRCA) in patients treated with Eprex epoetin, which is marketed in Europe

Read the full 291 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE